Uncategorized
Nicox acquires Carragelose eye drop program
Nicox announced it has agreed to acquire the Carragelose anti-viral eye drop program from Marinomed Biotechnologie for potential use in the management of viral conjunctivitis, according to a company release. In exchange, Marinomed received €2.65 million in newly issued Nicox shares and up to €2.65 in potential cash payments.